Q1 report is out April 30th according to NS Investor Centre.
Revenues around $7.8m I think is what guidance number to look for.
Have posted this link below from Youtube Dr Matthew Regulski
Dr Bashayl's presentation is on YT now as well.
Trying to get a link for Dr Lucian Vlad AAWC
Have followed NS for 3 years Judith always indicated 2026 as the year where significant revenues would be realised.
Cochlear Resmed CSL didn't always have $b turnover.
https://youtu.be/kHyoLpt0tKM?si=WuWDeVaRC3y3uWwN
Ann: Preliminary results of further XPERIENCE studies released, page-9
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.010(4.76%) |
Mkt cap ! $58.43M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $13.88K | 69.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8044 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 14.20pm 08/10/2024 (20 minute delay) ? |
| NXS (ASX) Chart |